Heron Therapeutics shares owned by Smith Asset Management Group
Quarter-by-quarter ownership of Heron Therapeutics (HRTX) shares owned by Smith Asset Management Group
from 13F filings
Historical chart of Smith Asset Management Group investment in Heron Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Heron Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Heron Therapeutics by Smith Asset Management Group
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2021-06-30 | $2.0k | 120 | 16.67 |
2021-03-31 | $2.0k | 120 | 16.67 |
2020-12-31 | $79k | 3.7k | 21.24 |
2020-09-30 | $55k | 3.7k | 14.78 |
2020-06-30 | $41k | 2.8k | 14.59 |
2020-03-31 | $33k | 2.8k | 11.62 |
2019-12-31 | $67k | 2.8k | 23.59 |
2019-09-30 | $53k | 2.8k | 18.66 |
2019-06-30 | $43k | 2.3k | 18.61 |
2019-03-31 | $56k | 2.3k | 24.24 |
2018-12-31 | $231k | 8.9k | 25.93 |
2018-09-30 | $282k | 8.9k | 31.65 |
More positions owned by Smith Asset Management Group
View all positions for Smith Asset Management Group